Received without fixative/in formalin, labeled _____ and “_____”, is a total liver explant (__ g and __ x __ x __ cm) with attached gallbladder (__ cm in length, __ cm in diameter). The liver is _____ (soft, firm, friable). The external surface is _____ (color, smooth, micronodular, macronodular, adhesion-covered, lacerated). The hilar main vessels and ducts are opened to reveal ____ (e.g. stricture, thrombus, mass). The hepatic ducts and their main branches are ____ (e.g. patent, stenotic, obstructed by ___) and show ___ (e.g. impacted stone, periductal fibrosis). The liver is serially sectioned in 1 cm interval to show a ____ (color) diffusely multinodular cut surface, with nodules ranging from __ to __ cm in diameter. There is a __ x __ x __ cm _____ encapsulated / unencapsulated (color, irregular, nodular, necrotic, hemorrhagic, circumscription, cystic) mass in the _____ lobe, __ cm from the _____ margin and __ cm from the nearest _____ (anterior, posterior, inferior, superior) capsular surface. There is (no) main vessel or duct nearby / __ cm from the mass. No dominant nodule or mass in the remaining liver parenchyma. The gallbladder has a _____ (describe) external surface and a _____ (describe) mucosal surface, with a wall thickness of __ cm. It contains approximately __ cc of _____ (describe) bile and __ (number) _____ (describe) stones, measuring __ x __ x __ cm in aggregate and ranging from __ to __ cm in diameter. No/multiple lymph nodes with _____ (describe) cut surfaces, ranging from __ to __ cm in diameter, are present in the hilum. Representatively submitted as follows:
# __ = hilar bile duct and vascular margin, cross section.
# __ = hepatic vein margin.
# __ = mass / dominant nodule / mass, with adjacent vessel / duct.
# __ = mass / dominant nodule / mass, with adjacent liver.
# __ = mass / dominant nodule / mass, with serosal surface.
# __ = non-neoplastic liver
# __ = hilar area and lymph node (bisected).
# __ = gallbladder and cystic duct margin (inked blue)
__ blocks, __ H&E